更多...
收起
TP53BP1基因(以及对应的蛋白质)的细胞分布位置:
TP53BP1基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Malignant neoplasm of lung | 0.008458305 | 6 | 1 | BeFree_GAD |
Squamous cell carcinoma | 0.007101096 | 3 | 0 | GAD |
Malignant neoplasm of breast | 0.005895776 | 13 | 0 | BeFree_GAD |
Head and Neck Neoplasms | 0.005091382 | 1 | 0 | GAD_LHGDN |
Adenocarcinoma | 0.005005506 | 3 | 0 | BeFree_GAD |
Esophageal Neoplasms | 0.005005506 | 3 | 0 | BeFree_GAD |
Breast Carcinoma | 0.003528744 | 13 | 0 | BeFree |
Mammary Neoplasms | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Prostatic Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Colorectal Neoplasms | 0.002638474 | 2 | 0 | BeFree_GAD |
Skin Neoplasms | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of esophagus | 0.002638474 | 2 | 0 | BeFree_GAD |
Basal cell carcinoma | 0.002367032 | 1 | 0 | GAD |
Gastroesophageal reflux disease | 0.002367032 | 1 | 0 | GAD |
Chronic Lymphocytic Leukemia | 0.002367032 | 1 | 0 | GAD |
Stomach Neoplasms | 0.002367032 | 1 | 0 | GAD |
Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
Lupus Erythematosus, Systemic | 0.001357209 | 5 | 0 | BeFree |
Carcinogenesis | 0.001357209 | 5 | 0 | BeFree |
Carcinoma of lung | 0.001357209 | 5 | 1 | BeFree |
Lupus Vulgaris | 0.001085767 | 4 | 0 | BeFree |
Lupus Erythematosus, Discoid | 0.001085767 | 4 | 0 | BeFree |
Ovarian Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Lupus Erythematosus | 0.001085767 | 4 | 0 | BeFree |
Malignant tumor of cervix | 0.000814326 | 3 | 2 | BeFree |
Cervix carcinoma | 0.000814326 | 3 | 2 | BeFree |
Ataxia Telangiectasia | 0.000542884 | 2 | 0 | BeFree |
Neoplasm Metastasis | 0.000542884 | 2 | 0 | BeFree |
Thyroid Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Tumor Progression | 0.000542884 | 2 | 0 | BeFree |
Pancreatic carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of ovary | 0.000542884 | 2 | 0 | BeFree |
Xenograft Model | 0.000542884 | 2 | 0 | BeFree |
Glioblastoma Multiforme | 0.000542884 | 2 | 0 | BeFree |
Riddle Syndrome | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
Chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Congenital chromosomal disease | 0.000271442 | 1 | 0 | BeFree |
Eosinophilia | 0.000271442 | 1 | 0 | BeFree |
Exanthema | 0.000271442 | 1 | 0 | BeFree |
Fanconi Anemia | 0.000271442 | 1 | 0 | BeFree |
Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Glioma | 0.000271442 | 1 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
Actinic keratosis | 0.000271442 | 1 | 0 | BeFree |
Myeloid Leukemia, Chronic | 0.000271442 | 1 | 0 | BeFree |
Chronic Obstructive Airway Disease | 0.000271442 | 1 | 0 | BeFree |
Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Multiple Myeloma | 0.000271442 | 1 | 0 | BeFree |
Precancerous Conditions | 0.000271442 | 1 | 0 | BeFree |
B-Cell Lymphomas | 0.000271442 | 1 | 0 | BeFree |
Thyroid Gland Follicular Adenoma | 0.000271442 | 1 | 0 | BeFree |
Follicular adenoma | 0.000271442 | 1 | 0 | BeFree |
Cervical Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Residual Cancer | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.000271442 | 1 | 0 | BeFree |
Diffuse Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of prostate | 0.000271442 | 1 | 0 | BeFree |
Thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Prostate carcinoma | 0.000271442 | 1 | 0 | BeFree |
Epithelial ovarian cancer | 0.000271442 | 1 | 0 | BeFree |
Spots on skin | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.000271442 | 1 | 0 | BeFree |
Papillary microcarcinoma | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.000271442 | 1 | 0 | BeFree |
Eosinophilic disorder | 0.000271442 | 1 | 0 | BeFree |
Invasive Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Skin Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Disorder characterized by eosinophilia | 0.000271442 | 1 | 0 | BeFree |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.000271442 | 1 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。